Your browser doesn't support javascript.
loading
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
D'Haens, Geert; Panaccione, Remo; Baert, Filip; Bossuyt, Peter; Colombel, Jean-Frederic; Danese, Silvio; Dubinsky, Marla; Feagan, Brian G; Hisamatsu, Tadakazu; Lim, Allen; Lindsay, James O; Loftus, Edward V; Panés, Julian; Peyrin-Biroulet, Laurent; Ran, Zhihua; Rubin, David T; Sandborn, William J; Schreiber, Stefan; Neimark, Ezequiel; Song, Alexandra; Kligys, Kristina; Pang, Yinuo; Pivorunas, Valerie; Berg, Sofie; Duan, W Rachel; Huang, Bidan; Kalabic, Jasmina; Liao, Xiaomei; Robinson, Anne; Wallace, Kori; Ferrante, Marc.
Afiliação
  • D'Haens G; Inflammatory Bowel Disease Centre, Amsterdam University Medical Center, Amsterdam, Netherlands. Electronic address: g.dhaens@amsterdamumc.nl.
  • Panaccione R; Inflammatory Bowel Disease Unit and Gastrointestinal Research, University of Calgary, Calgary, AB, Canada.
  • Baert F; AZ Delta, Roeselare, Belgium.
  • Bossuyt P; Department of Gastroenterology, Imelda General Hospital, Bonheiden, Belgium.
  • Colombel JF; Icahn School of Medicine at Mt Sinai, New York, NY, USA.
  • Danese S; Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital, Milan, Italy.
  • Dubinsky M; Icahn School of Medicine at Mt Sinai, New York, NY, USA.
  • Feagan BG; Division of Gastroenterology, Department of Medicine, University of Western Ontario, London, ON, Canada; Alimentiv, London, ON, Canada.
  • Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Lim A; University of Alberta, Edmonton, AB, Canada.
  • Lindsay JO; Centre for Immunobiology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Loftus EV; Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
  • Panés J; Department of Gastroenterology, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain.
  • Peyrin-Biroulet L; University of Lorraine, CHRU-Nancy, Department of Gastroenterology, Nancy, France; University of Lorraine, Inserm, NGERE, Nancy, France.
  • Ran Z; Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center, Shanghai, China; Renji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Institute of Digestive Disease,
  • Rubin DT; Section of Gastroenterology, Hepatology and Nutrition and Digestive Diseases Center, The University of Chicago Medicine, Chicago, IL, USA.
  • Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
  • Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
  • Neimark E; AbbVie, North Chicago, IL, USA.
  • Song A; AbbVie, North Chicago, IL, USA.
  • Kligys K; AbbVie, North Chicago, IL, USA.
  • Pang Y; AbbVie, North Chicago, IL, USA.
  • Pivorunas V; AbbVie, North Chicago, IL, USA.
  • Berg S; AbbVie, North Chicago, IL, USA.
  • Duan WR; AbbVie, North Chicago, IL, USA.
  • Huang B; AbbVie, North Chicago, IL, USA.
  • Kalabic J; AbbVie Deutschland, Ludwigshafen, Germany.
  • Liao X; AbbVie, North Chicago, IL, USA.
  • Robinson A; AbbVie, North Chicago, IL, USA.
  • Wallace K; AbbVie, North Chicago, IL, USA.
  • Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals, KU Leuven, Leuven, Belgium.
Lancet ; 399(10340): 2015-2030, 2022 05 28.
Article em En | MEDLINE | ID: mdl-35644154
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Doença de Crohn Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Doença de Crohn Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article